Download Launch of Montelukast lR Tablets and Chewable

@
ainntaphannnlimited
T
+9122 66061000
Mumbai400067
F +9122 66061200
E [email protected]
lndia
W
www.ajantapharma.com
Ajanta House,
charkop, Kandivli west.
3'd December, 2015
Nationat Stock Exchange of India
eii;nee ptaza, 5tF Ftoor, Ptot no. c/1, G Block
Bandra-Kurta Complex, Bandra {East),
BSE LIMITED
Phiroze Jeejeebhoy Towers
Dalal Street,
Mumbai - 400 001
Mumbai 400
051
Dear 5ir,
Eq
Scrip Code: BSE - AJANTPHAM 532331/ NSE AJANTPHARI
Sub,: Launch of ,iontelukast
lR
Tablet! and Montelukast Chewable Tablets in t'S market
Dear 5ir/Madam,
USA
to inform that our Company's subsidiary viz ' !"::". Pl*T:
Tabtets in US market' We
iaunlhet ti,tontetutast lR Tabtets and Montetuk"ast Chewabte
enctoseherewithapressreleasebeingjssuedbythecomPanyjnthjsregard,foryour
We are pteased
Inc
has
information and records.
Ptease acknowtedge the receiPt.
Thankng You,
Yours faithfuttY,
FoT AJANTA
PHARM LIMITED
/:,
-'4 l/t*
GAURANG SHAH
sr. G.M. - Legal &
Compony
seuetary
Encl.: a/a
Corborate ldentitv Number - t24230MH1979Ptd)22OS9
Press Release
BSE: 532331
NSE: AJANTPHARM
Reuters: AJPH.NS
Bloomberg: AJP:IN
Ajanta Pharma Announces the Launch of Montelukast IR
Tablets and Montelukast Chewable Tablets
Mumbai, India – (December 03rd, 2015) – Ajanta Pharma USA Inc., a subsidiary of Ajanta
Pharma Limited, announced today the launch of Montelukast Sodium IR Tablets (10mg) and
Montelukast Sodium Chewable Tablets (4mg & 5mg), generic versions of SINGULAIR® Tablets
and SINGULAIR® Chewable Tablets, respectively. The United States Food & Drug
Administration (US FDA) approval extends the breadth of the Montelukast offerings from
Ajanta Pharma into three dosage forms (Immediate-Release Tablets, Chewable Tablets, and
Oral Granules).
Montelukast IR Tablets and Chewable Tablets are part of an ever-growing portfolio that
Ajanta Pharma has developed for the US market. To date, the US FDA has granted Ajanta
Pharma five ANDA final approvals and two ANDA tentative approvals. An additional 19 ANDAs
are pending approval from the US FDA.
About Ajanta Pharma
Ajanta Pharma Limited is a fully-integrated pharmaceutical company with global
headquarters in Mumbai, India. Over 6,000 employees are engaged in developing,
manufacturing and marketing of quality finished dosages across 35 countries. Its mission is to
serve global healthcare needs through empathy, innovation and technology.
For
more
details about
www.ajantapharmausa.com.
Ajanta
Pharma
USA
Inc.,
please
visit
us
at
For Ajanta Pharma Ltd., you may visit us at www.ajantapharma.com.
For specific queries, contact:
Rajeev Agarwal Tel: +91 22 66061377 Email: [email protected]
SINGULAIR® is a registered trademark of Merck & Co., Inc.
Safe Harbour Statement
CIN: L24230MH1979PLC022059
Registered Office: 98, Ajanta House, Charkop, Kandivili (West), Mumbai, 400 067, India.
1